SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
WOJTOWICZ JEAN L

(Last) (First) (Middle)
3502 WOODVIEW TRACE
SUITE 210

(Street)
INDIANAPOLIS IN 46268

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
WINDROSE MEDICAL PROPERTIES TRUST [ WRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/20/2006
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 12/20/2006 D 1,327(1) D (2) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $14.7 12/20/2006 D 4,000 (3) 07/31/2016 Common Shares 4,000 (3) 0 D
Stock Options (right to buy) $15.11 12/20/2006 D 3,000 (4) 07/25/2015 Common Shares 3,000 (4) 0 D
Stock Option (right to buy) $12 12/20/2006 D 2,000 (5) 08/01/2014 Common Shares 2,000 (5) 0 D
Explanation of Responses:
1. Includes common shares acquired through the reinvestment of dividends under the Windrose Medical Properties Trust Direct Stock Purchase and Dividend Reinvestment Plan.
2. Disposed of pursuant to the Agreement and Plan of Merger, dated September 12, 2006, as amended by Amendment No. 1 to Agreement and Plan of Merger, by and among Health Care REIT, Inc., certain of it?s subsidiaries, Windrose Medical Properties Trust and Windrose Medical Properties L.P. (as amended, the "Merger Agreement"). Pursuant to the Merger Agreement the common shares were disposed of in exchange for 586 shares of common stock, $1.00 par value, of Health Care REIT, Inc. having a market value of $41.00 per share at the effective time of the merger.
3. This option, which provided for vesting in 2 equal installments beginning on August 1, 2006 and 2007, was converted into an option to purchase 1804 shares of common stock to Health Care REIT, Inc. at an exercise price of $32.60 per share.
4. This option, which provided for vesting in 2 equal installments beginning on July 26, 2006 and 2007, was converted into an option to purchase 1353 shares of common stock
5. This option, which provided for vesting in 2 equal installments beginning on August 1, 2005 and 2006, was converted into an option to purchase 902 shares of common stock
Remarks:
/s/ Jean Wojtowicz 12/22/2006
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.